Literature DB >> 14550540

2-Cyclopenten-1-one and prostaglandin J2 reduce restenosis after balloon angioplasty in rats: role of NF-kappaB.

Angela Ianaro1, Pasquale Maffia, Salvatore Cuzzocrea, Elena Mazzon, Maria Gabriella Santoro, Massimo Di Rosa, Armando Ialenti.   

Abstract

The aim of this study was to evaluate, using a rat model of balloon angioplasty, whether prostaglandin (PG) J(2) and 2-cyclopenten-1-one are able to reduce restenosis. We found that both PGJ(2) and 2-cyclopenten-1-one, administered by local application on carotid arteries, caused a dose-dependent inhibition of neointimal formation. Furthermore, both agents prevented vascular negative remodeling. The effect of these compounds on restenosis was correlated with an inhibition of nuclear factor-kappaB (NF-kappaB) activation as well as of intercellular adhesion molecule-1 (ICAM-1) protein expression in injured carotid arteries of control animals. Our results show that cyclopentenone PGs and their derivatives reduce restenosis and may have therapeutic relevance for the prevention of human restenosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14550540     DOI: 10.1016/s0014-5793(03)00873-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Ab initio calculations of molecular properties of low-lying electronic states of 2-cyclopenten-1-one--link with biological activity.

Authors:  Jana Fišanová; Ivan Cernušák; Vladimír Kellö
Journal:  J Mol Model       Date:  2012-06-13       Impact factor: 1.810

2.  Identification of Arsenic Direct-Binding Proteins in Acute Promyelocytic Leukaemia Cells.

Authors:  Tao Zhang; Haojie Lu; Weijun Li; Ronggui Hu; Zi Chen
Journal:  Int J Mol Sci       Date:  2015-11-10       Impact factor: 5.923

Review 3.  Suppressed anti-inflammatory heat shock response in high-risk COVID-19 patients: lessons from basic research (inclusive bats), light on conceivable therapies.

Authors:  Thiago Gomes Heck; Mirna Stela Ludwig; Matias Nunes Frizzo; Alberto Antonio Rasia-Filho; Paulo Ivo Homem de Bittencourt
Journal:  Clin Sci (Lond)       Date:  2020-08-14       Impact factor: 6.124

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.